COMPARATIVE PHARMACOKINETICS OF SILIPIDE AND SILYMARIN IN RATS

被引:124
作者
MORAZZONI, P
MONTALBETTI, A
MALANDRINO, S
PIFFERI, G
机构
[1] INVERNI BEFFA RES & DEV LABS,I-20141 MILAN,ITALY
[2] UNIV MILAN,IST CHIM FARMACEUT,I-20131 MILAN,ITALY
关键词
FLAVANOLIGNAN; SILYBIN; SILYMARIN; SILIPIDE; IDB; 1016; PHARMACOKINETICS;
D O I
10.1007/BF03188811
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The plasma level profile and the biliary excretion of silybin, the main flavanolignan component of silymarin, were evaluated in rats after single equimolar oral doses (200 mg/kg, expressed as silybin equivalents) of the silybin-phosphatidylcholine complex silipide (laboratory code IdB 1016) and of silymarin. Silybin was assayed by using a specific HPLC method which allowed also the determination of other flavanolignans present in the biological fluids after administration of silymarin (i.e. silydianin, silycristin and isosilybin).
引用
收藏
页码:289 / 297
页数:9
相关论文
共 22 条
[1]  
Arcari M, 1992, Boll Chim Farm, V131, P205
[2]   PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].
BARZAGHI, N ;
CREMA, F ;
GATTI, G ;
PIFFERI, G ;
PERUCCA, E .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338
[3]  
BULLES H, 1975, ARZNEIMITTEL-FORSCH, V25, P902
[4]   STUDIES ON THE ANTIOXIDANT AND FREE-RADICAL SCAVENGING PROPERTIES OF IDB-1016 A NEW FLAVANOLIGNAN COMPLEX [J].
COMOGLIO, A ;
LEONARDUZZI, G ;
CARINI, R ;
BUSOLIN, D ;
BASAGA, H ;
ALBANO, E ;
TOMASI, A ;
POLI, G ;
MORAZZONI, P ;
MAGISTRETTI, MJ .
FREE RADICAL RESEARCH COMMUNICATIONS, 1990, 11 (1-3) :109-115
[5]  
COMOGLIO A, 1972, FREE RAD RES COMMUN, V50, P1060
[6]   PROTECTIVE ACTIVITY OF SILIPIDE ON LIVER-DAMAGE IN RODENTS [J].
CONTI, M ;
MALANDRINO, S ;
MAGISTRETTI, MJ .
JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 60 (04) :315-321
[7]   RANDOMIZED CONTROLLED TRIAL OF SILYMARIN TREATMENT IN PATIENTS WITH CIRRHOSIS OF THE LIVER [J].
FERENCI, P ;
DRAGOSICS, B ;
DITTRICH, H ;
FRANK, H ;
BENDA, L ;
LOCHS, H ;
MERYN, S ;
BASE, W ;
SCHNEIDER, B .
JOURNAL OF HEPATOLOGY, 1989, 9 (01) :105-113
[8]  
FERENCI P, 1985, J HEPATOL, V1, pS229
[9]   STUDIES ON ELIMINATION OF SILYMARIN IN CHOLECYSTECTOMIZED PATIENTS .1. BILIARY AND RENAL ELIMINATION AFTER A SINGLE ORAL DOSE [J].
FLORY, PJ ;
KRUG, G ;
LORENZ, D ;
MENNICKE, WH .
PLANTA MEDICA, 1980, 38 (03) :227-237
[10]  
GABETTA B, 1989, Planta Medica, V55, P615, DOI 10.1055/s-2006-962168